
Within 3 weeks, mice that received topical ruxolitinib or tofacitinib had regrown nearly all their hair (right photo; drug was applied only to the right side of the mouse). Little to no hair growth occurred in control mice during the same timeframe (left photo). Credit: From S. Harel et al., Sci. Adv. 1, e1500973 (2015). Distributed under a Creative Commons Attribution Non Commercial License 4.0 (CC BY-NC). 10.1126/sciadv.1500973
2 FDA-approved drugs reawaken dormant hair follicles. Inhibiting a family of enzymes inside hair follicles that are suspended in a resting state restores hair growth, a new study has found...
Read More





Recent Comments